NOVA1 promotes SMN2 exon 7 splicing by binding the UCAC motif and increases SMN protein expression.
Ontology highlight
ABSTRACT: Spinal muscular atrophy (SMA) is a rare hereditary neuromuscular disease with a high lethality rate in infants. Variants in the homologous genes survival of motor neuron (SMN)1 and SMN2 have been reported to be SMA pathogenic factors. Previous studies showed that a high inclusion rate of SMN2 exon 7 increased SMN expression, which in turn reduced the severity of SMA. The inclusion rate of SMN2 exon 7 was higher in neural tissues than in non-neural tissues. Neuro-oncological ventral antigen (NOVA) is a splicing factor that is specifically and highly expressed in neurons. It plays a key role in nervous system development and in the induction of nervous system diseases. However, it remains unclear whether this splicing factor affects SMA. In this study, we analyzed the inclusion of SMN2 exon
SUBMITTER: Du LL
PROVIDER: S-EPMC9120702 | biostudies-literature | 2022 Nov
REPOSITORIES: biostudies-literature
ACCESS DATA